Author Micah J. Chapman has published a new memoir titled “The Book of Micah: A Journey from Survival to Purpose,” now available on Amazon and in bookstores nationwide.

The memoir chronicles Chapman’s personal experiences growing up between two households in the Rocky Mountains. The narrative covers his childhood, adolescence, and the challenges he faced during those formative years, including family separation, economic hardship, and periods of personal struggle.

Chapman’s account details his experiences with abandonment, poverty, and the process of navigating difficult circumstances during his youth. The book examines how these experiences shaped his perspective and eventual path forward.

“The Book of Micah” is structured as a chronological narrative, taking readers through various stages of the author’s life. The memoir explores themes of resilience, personal development, and overcoming adversity. The narrative spans multiple decades, beginning with Chapman’s early childhood years and continuing through his adolescence and young adulthood.

Throughout the narrative, Chapman addresses topics including family dynamics, the impact of geographical displacement, and the process of personal growth following periods of instability. The book examines both the immediate and long-term effects of childhood experiences on adult development.

The memoir is written in first-person perspective and incorporates reflective commentary on the author’s experiences. Chapman provides context for the events described and offers observations on how past circumstances influenced his life decisions.

The book documents Chapman’s transition from challenging early life conditions to a more stable foundation. The author traces his personal development through various life stages and the factors that contributed to changes in his circumstances.

“The Book of Micah” provides readers with an account of one individual’s experience navigating difficult family situations and the process of building a different future. The memoir is intended for readers interested in personal narratives about overcoming hardship.

Micah J. Chapman is a first-time author whose memoir draws from his personal experiences growing up in the Rocky Mountain region. “The Book of Micah: A Journey from Survival to Purpose” represents his debut publication.

The book is currently available for purchase through Amazon and select bookstores across the United States. 

Media Contact

Organization: Micah J Chapman

Contact Person: Micah J Chapman

Website: http://micahjchapman.com/

Email: Send Email

Contact Number: +19038803640

Country:United States

Release id:41369

The post Micah J. Chapman Releases Memoir The Book of Micah appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

Miami, FL 33101, United States, 18th Feb 2026 –Health Connect Alliance, an independent health education platform that provides reviews and guidance on GLP-1 medications and treatment providers, has released its rankings of telehealth platforms offering GLP-1 medications and named CoreAge Rx as the #1 recommended provider for weight management in 2026. The independent review evaluated more than 48 GLP-1 providers and awarded CoreAge Rx a 9.9 out of 10 rating, along with its Editor’s Choice designation and an A+ rating.

According to Health Connect Alliance, the rankings were based on key evaluation criteria including medical supervision, medication quality, treatment personalization, pricing transparency, and ongoing medical support. CoreAge Rx ranked at the top of the platform’s “Best Place to Get GLP-1 Medications” category, receiving the highest score among all reviewed providers.

The rankings page published by Health Connect Alliance lists CoreAge Rx as its #1 recommended GLP-1 provider, highlighting its premium GLP-1 program, access to FDA-approved semaglutide and tirzepatide, personalized treatment plans, and care provided under the supervision of board-certified physicians. The review also identifies CoreAge Rx as its “Editor’s Choice,” recognizing it as the platform’s top overall recommendation for GLP-1 treatment programs.

In its overall recommendation, Health Connect Alliance states that CoreAge Rx stands out as its top choice for individuals seeking GLP-1 medications for weight management. The platform notes that CoreAge Rx offers personalized treatment plans designed by board-certified physicians and provides ongoing medical supervision throughout treatment.

Health Connect Alliance’s editorial analysis outlines several factors that contributed to CoreAge Rx receiving the highest rating. One of the primary factors is medical supervision, which the platform identifies as a critical requirement for safe and legitimate GLP-1 treatment. The review emphasizes that reputable providers must require consultation with licensed healthcare professionals, conduct comprehensive health evaluations, and provide ongoing medical monitoring. CoreAge Rx was recognized for offering treatment programs overseen by board-certified physicians, ensuring clinical oversight throughout the treatment process.

Medication quality and sourcing were also identified as essential components in the rankings. Health Connect Alliance states that high-quality GLP-1 providers offer FDA-approved medications such as semaglutide and tirzepatide or compounded medications prepared by licensed compounding pharmacies that follow regulatory standards. The platform highlights that CoreAge Rx offers FDA-approved semaglutide and tirzepatide as part of its GLP-1 program.

Health Connect Alliance also notes the importance of personalized treatment plans in achieving successful outcomes. According to the review, personalized treatment plans allow healthcare providers to assess patient medical history, monitor progress, and adjust treatment protocols as needed. CoreAge Rx was recognized for providing individualized treatment plans developed and supervised by board-certified physicians.

The platform further emphasizes the importance of ongoing medical support throughout treatment. Health Connect Alliance explains that ongoing medical supervision allows healthcare providers to monitor progress, address potential side effects, and ensure safe and effective treatment. CoreAge Rx’s program includes ongoing medical support as part of its treatment structure, which contributed to its top ranking.

Health Connect Alliance’s review also provides broader clinical context about GLP-1 medications and their role in weight management. GLP-1 receptor agonists, including semaglutide and tirzepatide, mimic a naturally occurring hormone involved in regulating appetite and blood sugar. These medications slow gastric emptying, increase feelings of fullness, reduce appetite signals, and help stabilize blood sugar levels.

According to Health Connect Alliance, clinical research has shown that semaglutide may support reductions of approximately 10–15% of body weight, while tirzepatide may support reductions of approximately 15–26% when combined with lifestyle modifications and medical supervision. The platform notes that treatment outcomes vary based on individual health factors and adherence to treatment protocols.

Health Connect Alliance also explains that telehealth providers have expanded access to GLP-1 medications by enabling patients to complete medical consultations remotely and receive prescribed medications through direct-to-door delivery. The platform states that telehealth-based treatment programs can offer convenience, accessibility, and structured medical supervision.

As part of its rankings, Health Connect Alliance compared CoreAge Rx with other GLP-1 providers including Mochi Health, Ro, Noom, Remedy Meds, Hers, MEDVI, Eden, MyStart, and Clinic Secret. CoreAge Rx achieved the highest rating among all reviewed providers and was named the platform’s #1 overall recommendation.

Health Connect Alliance’s evaluation framework emphasizes that individuals seeking GLP-1 medications should verify provider medical credentials, confirm medication sourcing, review treatment policies, and ensure that licensed healthcare professionals are involved in prescribing and monitoring treatment.

The organization also highlights that legitimate GLP-1 providers require medical consultation prior to prescribing medication. This consultation allows licensed healthcare professionals to evaluate patient medical history, assess treatment eligibility, and ensure appropriate clinical oversight.

Health Connect Alliance describes its rankings and provider reviews as educational resources designed to help individuals make informed decisions about GLP-1 treatment programs. The platform states that its evaluation methodology focuses on medical supervision, treatment quality, safety standards, and transparency.

With its 9.9 out of 10 rating, Editor’s Choice designation, and #1 overall ranking among more than 48 reviewed providers, CoreAge Rx emerged as Health Connect Alliance’s highest-rated GLP-1 provider for weight management in 2026, reflecting the platform’s evaluation of medical supervision, personalized treatment plans, and access to FDA-approved semaglutide and tirzepatide.

For more info, visit: https://www.healthconnectalliance.com/glp-1/best

Media Contact

Organization: Health Connect Alliance

Contact Person: Ro Budo

Website: https://www.healthconnectalliance.com/

Email: Send Email

Contact Number: +13055550329

City: Miami

State: FL 33101

Country:United States

Release id:41550

The post Health Connect Alliance Names CoreAge Rx Best GLP-1 Provider for Weight Management in 2026, Awards 9.9-10 Rating and Editor’s Choice Designation appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

Wichita Falls, TX 76302, United States, 18th Feb 2026 – CoreAge Rx, a telehealth platform focused on weight management and prescription treatment delivered through a fully online model, has reported a significant review milestone, with more than 300 patients providing positive feedback highlighting the platform’s onboarding experience, ongoing support, and overall care journey. According to CoreAge Rx, the growing number of patient reviews reflects a streamlined telehealth experience designed to provide accessible and professionally supervised weight management services.

The milestone underscores CoreAge Rx’s continued focus on delivering weight management care through a digital platform that allows patients to complete consultations remotely, receive physician evaluation, and access prescription treatment when appropriate. The company states that patient feedback consistently points to the clarity of the onboarding process and the structured approach to guiding patients through each stage of their care.

According to information provided by CoreAge Rx, patients begin the process by completing an online health assessment, which is reviewed by licensed medical professionals. This evaluation allows physicians to determine eligibility and develop individualized treatment plans based on each patient’s medical profile and weight management goals. The company reports that this structured onboarding system helps ensure that patients understand their care plan and receive appropriate medical supervision.

CoreAge Rx reports that ongoing support is another key factor contributing to patient satisfaction. Rather than limiting care to a one-time consultation, the platform provides continued access to medical guidance and treatment monitoring. Patient reviews provided to the company highlight the importance of continued communication and support throughout the weight management process, allowing patients to remain engaged and informed as they progress through treatment.

The company states that its telehealth platform is designed to remove many of the traditional barriers associated with in-person care. By enabling patients to complete evaluations and receive prescriptions remotely, CoreAge Rx provides a convenient alternative to traditional clinic visits. This remote care model allows patients to access weight management services from their home environment, reducing the need for travel and scheduling constraints.

CoreAge Rx also reports that physician supervision is a central component of its care model. According to the company, board-certified medical professionals review patient information, determine eligibility, and prescribe medications when appropriate. This physician-guided approach helps ensure that treatment decisions are based on individual health profiles and medical evaluation.

The company further states that prescription medications, when approved, are shipped directly to patients, allowing individuals to begin treatment without delays associated with traditional pharmacy visits. This delivery model supports the company’s goal of providing accessible and convenient weight management care through its telehealth platform.

According to CoreAge Rx, the review milestone reflects the company’s continued growth and patient engagement in the telehealth weight management space. The company reports that patient feedback consistently highlights the structured onboarding process, physician-guided care, and ongoing support as key factors contributing to the overall patient experience.

CoreAge Rx states that its digital-first approach is designed to provide patients with a clear and structured pathway, beginning with initial assessment, followed by physician evaluation, treatment approval when appropriate, and continued support. This step-by-step process is intended to ensure that patients receive care aligned with their individual needs.

The company reports that its telehealth model is built around accessibility, convenience, and physician oversight, allowing patients to access professional weight management care without requiring in-person clinic visits. According to CoreAge Rx, this approach reflects its commitment to providing modern healthcare solutions through digital technology.

CoreAge Rx further reports that the milestone of more than 300 patient reviews represents an important indicator of patient engagement and experience within its platform. The company states that patient feedback continues to inform its ongoing efforts to provide structured, physician-supervised weight management care through telehealth.

As telehealth adoption continues to expand, CoreAge Rx reports that its focus remains on maintaining a streamlined patient experience from onboarding through ongoing care. The company states that its review milestone reflects its continued commitment to delivering accessible, physician-guided weight management services through a fully online platform.

For more information, visit https://www.coreagerx.com/

Inquiries can be submitted through the official website contact page.
 

Media Contact

Organization: CoreAge Rx

Contact Person: Ella Jones

Website: https://www.coreagerx.com/

Email: Send Email

Contact Number: +19404004927

City: Wichita Falls

State: TX 76302

Country:United States

Release id:41548

Disclaimer: This content is provided for informational purposes only and does not constitute medical advice. Medical treatments require evaluation and prescription by licensed healthcare professionals.

The post Review Milestone: Why 300+ Patients Rated CoreAge Rx Among the Best in Online Weight Management Telehealth appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section